Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

交易中 05-01 12:12:11 EDT

0.2565

-0.0017

-0.66%

最高0.2950	最低0.2430	成交量136.08万
今开0.2582	昨收0.2582	日振幅20.14%
总市值5,318万	流通市值325.95万	总股本2.07亿
成交额36.17万	换手率10.71%	流通股本1,271万
市净率-24.46	ROE-807.39%	每股收益-2.09
52周最高4.00	52周最低0.1706	市盈率-0.12
股息0.60	股息收益率2.34	ROA-116.33%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":0.2565,"timestamp":1746115871226,"preClose":0.2582,"halted":0,"volume":1360845,"delay":0,"floatShares":12707564,"shares":207336389,"eps":-2.093595,"marketStatus":"交易中","change":-0.0017,"latestTime":"05-01 12:12:09 EDT","open":0.2582,"high":0.295,"low":0.243,"amount":361724.1681825,"amplitude":0.201394,"askPrice":0.2565,"askSize":300,"bidPrice":0.252,"bidSize":834,"shortable":0,"etf":0,"ttmEps":-2.093595,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1079413200000,"exchange":"NASDAQ","adjPreClose":0.2582,"preHourTrading":{"tag":"盘前","latestPrice":0.2582,"preClose":0.2582,"latestTime":"09:29 EDT","volume":104899,"amount":27309.6888873,"timestamp":1746106166273},"postHourTrading":{"tag":"盘后","latestPrice":0.254,"preClose":0.2582,"latestTime":"19:59 EDT","volume":132204,"amount":34077.639,"timestamp":1746057597531},"volumeRatio":0.125745,"impliedVol":6.1603,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/CYCC/tweets","defaultTab":"tweets","newsList":[{"id":"2531055423","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌17.54%报0.251美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531055423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531055423?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:33","pubTimestamp":1746020007,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时33分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速跳水17.54%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Regulus Therapeutics Inc.、Nutriband Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为127.23%、14.51%、10.88%，振幅较大的相关个股有Polypid Ltd.、Nutriband Inc.、Aligos Therapeutics, Inc.，振幅分别为14.43%、13.91%、12.57%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213327a6cee8a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213327a6cee8a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2531069728","title":"Cyclacel Pharmaceuticals, Inc.4月29日成交额为3697.41万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531069728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531069728?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:25","pubTimestamp":1745976351,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Cyclacel Pharmaceuticals, Inc.成交额为3697.41万美元，成交额较昨日增加891.43%，当日成交量为1.10亿股。Cyclacel Pharmaceuticals, Inc.于2025年4月29日涨124.54%，报0.304美元，该股过去5个交易日涨34.42%，年初至今跌19.2%，过去60日跌8.77%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|3697.41万|891.43%|1.10亿|#|2025-04-28|372.94万|274.66%|1098.05万|#|2025-04-25|99.54万|1047.06%|374.58万|#|2025-04-24|8.68万|-33.87%|37.80万|#|2025-04-23|13.12万|864.38%|57.88万|Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430092559a6ce13fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430092559a6ce13fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2531758573","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅上涨72.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531758573?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933461,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速拉升72.58%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为129.19%、37.38%、11.24%，振幅较大的相关个股有Promis Neurosciences Inc.、Cue Biopharma, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为9.62%、8.77%、5.43%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213101a46c3ef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213101a46c3ef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2530134176","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530134176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530134176?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:54","pubTimestamp":1745589252,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时54分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.24%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Jaguar Health, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为227.43%、72.97%、43.87%，振幅较大的相关个股有Onconetix, Inc.、Coeptis Therapeutics Holdings, Inc.、Azitra Inc，振幅分别为25.80%、23.10%、22.68%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215412a466e7f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215412a466e7f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2529371586","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529371586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529371586?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:30","pubTimestamp":1745328624,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时30分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速拉升6.58%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ibio, Inc.、Orchestra Biomed Holdings, Inc.、Xbiotech Inc.涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃，换手率分别为156.98%、92.76%、33.92%，振幅较大的相关个股有Vincerx Pharma, Inc.、Traws Pharma, Inc.、Maze Therapeutics, Inc.，振幅分别为12.23%、6.25%、6.24%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213025a4628907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213025a4628907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2529876413","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌6.59%报0.211美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529876413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529876413?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:04","pubTimestamp":1745251493,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日00时04分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下挫6.59%。截至发稿，该股报0.211美元/股，成交量3.6148万股，换手率0.02%，振幅6.24%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422000454973f9288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422000454973f9288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2528427100","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528427100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528427100?lang=zh_cn&edition=full","pubTime":"2025-04-17 03:16","pubTimestamp":1744830978,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日03时16分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下挫6.06%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.86%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Dermata Therapeutics Inc C/Wts 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Briacell Therapeutics Corp.、Transcode Therapeutics, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为525.31%、318.23%、185.71%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为90.48%、49.00%、48.11%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417031619aa2c7230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417031619aa2c7230&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2527417559","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨5.39%报0.235美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527417559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527417559?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:45","pubTimestamp":1744724702,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时45分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.39%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为530.35%、213.66%、84.67%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.，振幅分别为80.08%、66.02%、38.78%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214502a459c929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214502a459c929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2517297669","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨5.14%报0.344美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517297669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517297669?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:42","pubTimestamp":1741207324,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时42分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.14%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Bioxcel Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为981.12%、319.85%、319.68%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为497.01%、82.59%、54.27%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044205abea1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044205abea1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2516677853","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677853?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:34","pubTimestamp":1741098857,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时34分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.43%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1067.09%、1063.20%、420.28%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、11.23%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223417a25f058c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223417a25f058c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2514336403","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速拉升9.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514336403?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:38","pubTimestamp":1740681511,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时38分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨9.00%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Pepgen Inc.、Quoin Pharmaceuticals Ltd、Vincerx Pharma, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1828.24%、316.04%、134.60%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228023832abdfa64f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228023832abdfa64f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2514201829","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201829?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:58","pubTimestamp":1740495535,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时58分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.10%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为982.09%、737.33%、564.47%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为121.95%、46.65%、43.70%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225855962ff8f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225855962ff8f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2512165555","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报0.353美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165555?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:40","pubTimestamp":1739889604,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时40分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.14%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为298.67%、103.64%、82.70%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182240059889fe9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182240059889fe9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2511697356","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速上涨5.06%报0.345美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511697356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511697356?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:12","pubTimestamp":1739549523,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时12分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.06%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2676.24%、701.91%、531.79%，振幅较大的相关个股有Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为66.93%、58.14%、54.40%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215001203abcf1d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215001203abcf1d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2511521094","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅拉升6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511521094?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:31","pubTimestamp":1739460691,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.84%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2316.90%、1134.09%、153.57%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132331319621c8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132331319621c8ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2510886934","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510886934?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:42","pubTimestamp":1739198556,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时42分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.76%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1989.16%、1090.45%、713.20%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.，振幅分别为69.90%、51.35%、39.80%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210224236abc9a815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210224236abc9a815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2509720406","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 急速跳水5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509720406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509720406?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:57","pubTimestamp":1738954673,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时57分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.89%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8165.11%、179.29%、128.72%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.40%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025754a23d5a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025754a23d5a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2509725812","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509725812?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:42","pubTimestamp":1738852936,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时42分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.01%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4456.51%、608.47%、119.56%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Azitra Inc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为61.63%、35.69%、35.22%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224217987c90c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224217987c90c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2508149509","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.11%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149509?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为373.12%、156.24%、57.57%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为82.17%、33.33%、27.90%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322385798797059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322385798797059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2507657009","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.13%报0.340美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507657009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507657009?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:31","pubTimestamp":1738333873,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.13%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nls Pharmaceutics Ltd.、Nutriband Inc C/Wts 涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1095.19%、213.35%、54.06%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Eyenovia, Inc.、Monopar Therapeutics Inc.，振幅分别为11.62%、11.17%、9.48%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312231149614ea95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312231149614ea95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":0.1216},{"period":"1month","weight":-0.0752},{"period":"3month","weight":-0.2796},{"period":"6month","weight":-0.5881},{"period":"1year","weight":-0.8782},{"period":"ytd","weight":-0.3133}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.210526,"avgChangeRate":-0.011871},{"month":2,"riseRate":0.421053,"avgChangeRate":0.076812},{"month":3,"riseRate":0.368421,"avgChangeRate":-0.064253},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014837},{"month":5,"riseRate":0.421053,"avgChangeRate":-0.011259},{"month":6,"riseRate":0.157895,"avgChangeRate":-0.101938},{"month":7,"riseRate":0.526316,"avgChangeRate":-0.038718},{"month":8,"riseRate":0.263158,"avgChangeRate":-0.093712},{"month":9,"riseRate":0.473684,"avgChangeRate":-0.008621},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.007856},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.031831},{"month":12,"riseRate":0.473684,"avgChangeRate":-0.021725}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}